APA (7th ed.) Citation

M, K. (2024). Editorial Comment on "Efficacy of pembrolizumab plus lenvatinib as first-line treatment for metastatic renal cell carcinoma with multiple brain metastases". IJU case reports, 8(1), 9. https://doi.org/10.1002/iju5.12805

Chicago Style (17th ed.) Citation

M, Kato. "Editorial Comment on "Efficacy of Pembrolizumab Plus Lenvatinib as First-line Treatment for Metastatic Renal Cell Carcinoma with Multiple Brain Metastases"." IJU Case Reports 8, no. 1 (2024): 9. https://doi.org/10.1002/iju5.12805.

MLA (9th ed.) Citation

M, Kato. "Editorial Comment on "Efficacy of Pembrolizumab Plus Lenvatinib as First-line Treatment for Metastatic Renal Cell Carcinoma with Multiple Brain Metastases"." IJU Case Reports, vol. 8, no. 1, 2024, p. 9, https://doi.org/10.1002/iju5.12805.